Targeted Therapies and their Impact on Melanoma
Steven O’Day, MD
Video Categories: Targeted Therapies
Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.
Dr. Sanjiv Agarwala addresses the possibility of updating indications for Nivolumab and Pembrolizumab in the therapeutic arena.
In this second clinical commentary entitled, Management of Patients with Basal Cell Carcinoma not Eligible for Surgery or Radiation, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss the need for new treatment options in the care of basal cell carcinoma [ Read More ]